L.A. Drug Linchpin Who Sold Matthew Perry Ketamine Sentenced to 15 Years

A Los Angeles drug dealer known as the 'Ketamine Queen' was sentenced to 15 years in federal prison on Tuesday, May 21, 2024, for supplying the ketamine that led to the fatal overdose of actor Matthew Perry in October 2023. The sentencing of Jasveen Sangha, 45, concluded a high-profile case that linked the illicit drug trade directly to a celebrity death, highlighting the dangers of unregulated substances and the reach of narcotics networks in major cities. The case centered on evidence presented by federal prosecutors from the U.S. Attorney's Office for the Central District of California, who detailed how Sangha operated a sophisticated drug distribution ring. She was identified as a primary supplier to a network that catered to affluent clients in the Los Angeles area. The ketamine she sold was traced through forensic analysis to the batch found in Perry's system at the time of his death. Prosecutors argued successfully that her actions directly contributed to a death, warranting a significant prison term under federal sentencing guidelines for drug distribution resulting in death or serious bodily injury. The sentencing brings a measure of legal closure to a tragedy that shocked fans worldwide and sparked broader conversations about addiction and the opioid crisis. While Perry's death was officially ruled an accident from the 'acute effects of ketamine,' with contributing factors including drowning, coronary artery disease, and the effects of buprenorphine, the criminal case underscored the lethal potential of black-market pharmaceuticals. The investigation revealed how dealers like Sangha exploit demand for party and therapeutic drugs, often masking dangerous purity levels or mixtures. The judge's remarks during sentencing emphasized the dealer's culpability in perpetuating a cycle of addiction and tragedy, regardless of the user's celebrity status. This case is part of a larger federal crackdown on narcotics distribution in Southern California, particularly targeting suppliers connected to overdose deaths. It serves as a stark warning to drug traffickers about the severe consequences when their products cause fatalities. For the public and Perry's legacy, it reinforces ongoing efforts to combat substance abuse and improve access to regulated, safe treatment options, moving the discussion beyond celebrity gossip to systemic issues of drug policy and public health.